Recurrence of GBM after chemo-radiation could be associated with a switch of angiogenic pattern from VEGFR2-HIF1α to CXCL12-CXCR4 pathway, leading to new perspectives in angiogenic treatment. This evidence concerns the gene CXCR4 and glioblastoma.